Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Classement en actions #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$4.04K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CA
Échange Xeno Transplants Corporation (XENO)

Catégorie

Historique du prix de l'action pour Xeno Transplants Corporation (XENO)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $0.33 le 2006-08-01
Historique du prix de l'action de Xeno Transplants Corporation de 2006 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -50.00%
2022 100.00%
2021 -93.74%
2020 -73.43%
2019 102.25%
2018 -7.07%
2017 67.54%
2016 -45.43%
2015 153.29%
2014 -23.64%
2013 -9.52%
2012 -44.74%
2011 -59.79%
2010 332.31%
2009 -85.91%
2008 -96.85%
2007 -72.30%
2006 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -8.05%
KR